Z85.42 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Personal history of malignant neoplasm of oth prt uterus. The 2020 edition of ICD-10-CM Z85.42 became effective on October 1, 2019.
C54.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM C54.1 became effective on October 1, 2020. This is the American ICD-10-CM version of C54.1 - other international versions of ICD-10 C54.1 may differ.
Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified ( C25.9 ). Primary or metastatic malignant neoplasm involving the endometrium (mucous membrane that lines the endometrial cavity).
Current: Cancer is coded as current if the record clearly states active treatment is for the purpose of curing or palliating cancer, or states cancer is present but unresponsive to treatment; the current treatment plan is observation or watchful waiting; or the patient refused treatment.
Leiomyoma of uterus, unspecified D25. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D25. 9 became effective on October 1, 2021.
ICD-10 code: C55 Malignant neoplasm of uterus, part unspecified.
ICD-10 code N93. 9 for Abnormal uterine and vaginal bleeding, unspecified is a medical classification as listed by WHO under the range - Diseases of the genitourinary system .
ICD-10 code C54. 1 for Malignant neoplasm of endometrium is a medical classification as listed by WHO under the range - Malignant neoplasms .
Z90. 710 - Acquired absence of both cervix and uterus | ICD-10-CM.
C54. 1 - Malignant neoplasm of endometrium | ICD-10-CM.
ICD-10 code B96. 89 for Other specified bacterial agents as the cause of diseases classified elsewhere is a medical classification as listed by WHO under the range - Certain infectious and parasitic diseases .
Unspecified abnormal cytological findings in specimens from cervix uteri. R87. 619 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM R87.
Abnormal uterine bleeding (AUB) is bleeding from the uterus that is longer than usual or that occurs at an irregular time. Bleeding may be heavier or lighter than usual and occur often or randomly. AUB can occur: As spotting or bleeding between your periods. After sex.
ICD-10 code: C54. 1 Malignant neoplasm: Endometrium.
Other benign neoplasm of uterus, unspecified D26. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D26. 9 became effective on October 1, 2021.
Metastatic uterine (endometrial) cancer is a type of cancer that originated in the lining of the uterus (endometrium) and has spread to distant areas of the body. In general, uterine cancer can metastasize to the rectum or bladder. Other areas where it may spread include the vagina, ovaries and fallopian tubes.
Personal history of other diseases of the female genital tract 1 Z87.42 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 Short description: Personal history of oth diseases of the female genital tract 3 The 2021 edition of ICD-10-CM Z87.42 became effective on October 1, 2020. 4 This is the American ICD-10-CM version of Z87.42 - other international versions of ICD-10 Z87.42 may differ.
The 2022 edition of ICD-10-CM Z87.42 became effective on October 1, 2021.
The 2022 edition of ICD-10-CM Z80.49 became effective on October 1, 2021.
Z77-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status
The 2022 edition of ICD-10-CM Z85.3 became effective on October 1, 2021.
Z77-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The 2022 edition of ICD-10-CM C54.1 became effective on October 1, 2021.
Approximate Synonyms. Adenocarcinoma of endometrium. Cancer of the endometrium. Cancer of the endometrium, adenocarcinoma. Cancer of the endometrium, adenosquamous. Cancer of the endometrium, clear cell. Cancer of the endometrium, mixed mullerian. Cancer of the endometrium, papillary serous.
For more context, consider the meanings of “current” and “history of” (ICD-10-CM Official Guidelines for Coding and Reporting; Mayo Clinic; Medline Plus, National Cancer Institute):#N#Current: Cancer is coded as current if the record clearly states active treatment is for the purpose of curing or palliating cancer, or states cancer is present but unresponsive to treatment; the current treatment plan is observation or watchful waiting; or the patient refused treatment.#N#In Remission: The National Cancer Institute defines in remission as: “A decrease in or disappearance of signs or symptoms of cancer. Partial remission, some but not all signs and symptoms of cancer have disappeared. Complete remission, all signs and symptoms of cancer have disappeared, although cancer still may be in the body.”#N#Some providers say that aromatase inhibitors and tamoxifen therapy are applied during complete remission of invasive breast cancer to prevent the invasive cancer from recurring or distant metastasis. The cancer still may be in the body.#N#In remission generally is coded as current, as long as there is no contradictory information elsewhere in the record.#N#History of Cancer: The record describes cancer as historical or “history of” and/or the record states the current status of cancer is “cancer free,” “no evidence of disease,” “NED,” or any other language that indicates cancer is not current.#N#According to the National Cancer Institute, for breast cancer, the five-year survival rate for non-metastatic cancer is 80 percent. The thought is, if after five years the cancer isn’t back, the patient is “cancer free” (although cancer can reoccur after five years, it’s less likely). As coders, it’s important to follow the documentation as stated in the record. Don’t go by assumptions or averages.
According to the ICD-10 guidelines, (Section I.C.2.m):#N#When a primary malignancy has been excised but further treatment, such as additional surgery for the malignancy, radiation therapy, or chemotherapy is directed to that site, the primary malignancy code should be used until treatment is complete.#N#When a primary malignancy has been excised or eradicated from its site, there is no further treatment (of the malignancy) directed to that site, and there is no evidence of any existing primary malignancy, a code from category Z85, Personal history of malignant neoplasm, should be used to indicate the former site of the malignancy.#N#Section I.C.21.8 explains that when using a history code, such as Z85, we also must use Z08 Encounter for follow-up examination after completed treatment for a malignant neoplasm. This follow-up code implies the condition is no longer being actively treated and no longer exists. The guidelines state:#N#Follow-up codes may be used in conjunction with history codes to provide the full picture of the healed condition and its treatment.#N#A follow-up code may be used to explain multiple visits. Should a condition be found to have recurred on the follow-up visit, then the diagnosis code for the condition should be assigned in place of the follow-up code.#N#For example, a patient had colon cancer and is status post-surgery/chemo/radiation. The patient chart notes, “no evidence of disease” (NED). This is reported with follow-up code Z08, first, and history code Z85.038 Personal history of other malignant neoplasm of large intestine, second. The cancer has been removed and the patient’s treatment is finished.
This follow-up code implies the condition is no longer being actively treated and no longer exists. The guidelines state: Follow-up codes may be used in conjunction with history codes to provide the full picture of the healed condition and its treatment. A follow-up code may be used to explain multiple visits.
History of Cancer: The record describes cancer as historical or “history of” and/or the record states the current status of cancer is “cancer free,” “no evidence of disease,” “NED,” or any other language that indicates cancer is not current. According to the National Cancer Institute, for breast cancer, the five-year survival rate ...
The fear is, history of will be seen as a less important diagnosis, which may affect relative value units . Providers argue that history of cancer follow-up visits require meaningful review, examinations, and discussions with the patients, plus significant screening and watching to see if the cancer returns.